CAS: 53230-10-7 - 4-Quinolinemethanol, α-(2R)-2-piperidinyl-2,8-bis(trifluoromethyl)-, (αS)-rel-
Formula:C17H16F6N2O
InChI:InChI=1/C17H16F6N2O/c18-16(19,20)11-5-3-4-9-10(15(26)12-6-1-2-7-24-12)8-13(17(21,22)23)25-14(9)11/h3-5,8,12,15,24,26H,1-2,6-7H2/t12-,15+/s2
InChI key:InChIKey=XEEQGYMUWCZPDN-OPNJQGHXNA-N
SMILES:FC(F)(F)C1=NC2=C(C=CC=C2C(F)(F)F)C(=C1)C(O)C3NCCCC3
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Mefloquine Hydrochloride REF: 3B-M2313CAS: | >98.0%(HPLC) | 113.00 € | Tue 10 Dec 24 |
 | Mefloquine REF: TM-T0860LCAS: 53230-10-7 | 99.97% | 143.00 €~1,412.00 € | Mon 16 Dec 24 |
 | Mefloquine HCl REF: 4Z-M-821CAS: | - - - | To inquire | Tue 17 Dec 24 |
 | Mefloquine REF: 3D-FM41874CAS: 53230-10-7 | Min. 95% | To inquire | Mon 27 Jan 25 |
Mefloquine Hydrochloride
Formula:
C17H16F6N2O·HCl
Purity:
>98.0%(HPLC)
Color and Shape:
White to Almost white powder to crystal
Molecular weight:
414.78
Ref: 3B-M2313
| 1g | 113.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Mefloquine
CAS:53230-10-7
Mefloquine (Ro 215998), a quinoline antimalarial agent, is an anti-SARS-CoV-2 entry inhibitor.
Formula:
C17H16F6N2O
Purity:
99.97%
Color and Shape:
Solid
Molecular weight:
378.31
Ref: TM-T0860L
| 1mg | 143.00 € | ||
| 5mg | 312.00 € | ||
| 10mg | 462.00 € | ||
| 25mg | 736.00 € | ||
| 50mg | 1,054.00 € | ||
| 100mg | 1,412.00 € | ||
| 1mL*10mM (DMSO) | 345.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
Ref: 4Z-M-821
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 17 Dec 2024
Mefloquine
CAS:53230-10-7
Mefloquine is a drug that is used for the treatment of malaria. It binds to …
Formula:
C17H16F6N2O
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
378.31 g/mol
Ref: 3D-FM41874
| 25mg | 232.00 € | ||
| 50mg | 364.00 € | ||
| 100mg | 517.00 € | ||
| 250mg | 863.00 € | ||
| 500mg | 1,160.00 € |
Estimated delivery in United States, on Monday 27 Jan 2025
